Definition of Avelumab. Meaning of Avelumab. Synonyms of Avelumab

Here you will find one or more explanations in English for the word Avelumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Avelumab and, of course, Avelumab synonyms and on the right images related to the word Avelumab.

Definition of Avelumab

No result for Avelumab. Showing similar results...

Meaning of Avelumab from wikipedia

- Avelumab, sold under the brand name Bavencio, is a fully human monoclonal antibody medication for the treatment of Merkel cell carcinoma, urothelial carcinoma...
- non-small cell lung cancer. Avelumab (Bavencio) is a fully human IgG1 antibody developed by Merck Serono and Pfizer. Avelumab is FDA approved for the treatment...
- was approved for medical use in the United States in September 2024. Avelumab, sold under the brand name Bavencio, is a fully human monoclonal antibody...
- studied. Dostarlimab exhibits better efficacy than PD-L1 inhibitors, such as avelumab and durvalumab, in dMMR advanced endometrial cancers. Efficacy of the drug...
- Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 BMS-202 Atezolizumab Avelumab Durvalumab KN035 Cosibelimab AUNP12 CA-170 BMS-986189...
- results in more progression of the cancer than pembrolizumab, axitinib and avelumab. In comparison to pembrolizumab and axitinib, it probably results in more...
- Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 BMS-202 Atezolizumab Avelumab Durvalumab KN035 Cosibelimab AUNP12 CA-170 BMS-986189...
- Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 BMS-202 Atezolizumab Avelumab Durvalumab KN035 Cosibelimab AUNP12 CA-170 BMS-986189...
- the U.S. Food and Drug Administration granted accelerated approval to avelumab, a PDL1 inhibitor, to treat adults and children above 12 years with metastatic...
- work has led to the establishment of several novel drugs (cabozantinib, avelumab, pazopanib and others including combinations) and prognostic factors in...